Effects of HIV/HCV co-infection on the efficacy of antiretroviral treatment for HIV: a meta-analysis of 5408 patients in 10 randomised clinical trials

被引：0
|
作者：
Pulido, F. [1 ]
Hill, A. [2 ]
van Delft, Y. [3 ]
Moecklinghoff, C. [4 ]
机构：
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
[2] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[3] Janssen, Tilburg, Netherlands
[4] Janssen, Neuss, Germany
来源：
HIV MEDICINE | 2012年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [41] Treatment of acute HCV infection in HIV co-infection: Influence of HCV genotype and ribavirin upon treatment outcome
    Boesecke, Christoph
    Ingiliz, Patrick
    Stellbrink, Hans-Juergen
    Nelson, Mark
    Page, Emma E.
    Bhagani, Sanjay
    Guiguet, Marguerite
    Valantin, Marc-Antoine
    Reiberger, Thomas
    Vogel, Martin
    Rockstroh, Juergen K.
    HEPATOLOGY, 2012, 56 : 215A - 215A
  • [42] Bedaquiline in the treatment of patients with co-infection HIV/tuberculosis
    Galstyan, Armine
    Borisov, Sergey Evgenievich
    Sinitsin, Michail
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome
    Christoph Boesecke
    Patrick Ingiliz
    Thomas Reiberger
    Hans-Jürgen Stellbrink
    Sanjay Bhagani
    Emma Page
    Stefan Mauss
    Thomas Lutz
    Esther Voigt
    Marguerite Guiguet
    Marc-Antoine Valantin
    Axel Baumgarten
    Mark Nelson
    Martin Vogel
    Jürgen K. Rockstroh
    Infection, 2016, 44 : 93 - 101
  • [44] Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome
    Boesecke, Christoph
    Ingiliz, Patrick
    Reiberger, Thomas
    Stellbrink, Hans-Juergen
    Bhagani, Sanjay
    Page, Emma
    Mauss, Stefan
    Lutz, Thomas
    Voigt, Esther
    Guiguet, Marguerite
    Valantin, Marc-Antoine
    Baumgarten, Axel
    Nelson, Mark
    Vogel, Martin
    Rockstroh, Jurgen K.
    INFECTION, 2016, 44 (01) : 93 - 101
  • [45] TIME TO DAA TREATMENT FOR HCV DISFAVORS PATIENTS WITH HCV/HIV CO-INFECTION: AN URBAN TERTIARY CLINIC EXPERIENCE
    Sims, Omar T.
    Wang, Kaiying
    GASTROENTEROLOGY, 2020, 158 (06) : S1358 - S1359
  • [46] SARS-CoV-2 and HIV co-infection; clinical features, diagnosis, and treatment strategies: A systematic review and meta-analysis
    Dadashi, Masoud
    Dadashi, Ali
    Sameni, Fatemeh
    Sayadi, Shahram
    Goudarzi, Mehdi
    Nasiri, Mohammad Javad
    Yaslianifard, Somayeh
    Ghazi, Mona
    Arjmand, Reza
    Hajikhani, Bahareh
    GENE REPORTS, 2022, 27
  • [47] Treatment after liver biopsy in patients with hepatitis C virus (HCV) and HIV co-infection
    Gopal, Kavitha
    Suwandhi, Pauline
    Broder, Arkady
    Bodenheimer, Henry C.
    Min, Albert D.
    GASTROENTEROLOGY, 2008, 134 (04) : A832 - A832
  • [48] A meta-analysis on the prevalence and characteristics of severe malaria in patients with Plasmodium spp. and HIV co-infection
    Aongart Mahittikorn
    Kwuntida Uthaisar Kotepui
    Giovanni De Jesus Milanez
    Frederick Ramirez Masangkay
    Manas Kotepui
    Scientific Reports, 11
  • [49] Mitochondrial Abnormalities in Patients with HIV-HCV Co-infection as Compared to Patients with HCV Mono-infection
    Chapplain, Jean-Marc
    Tattevin, Pierre
    Guyader, Dominique
    Begue, Jean-Marc
    Beillot, Jocelyne
    Turlin, Bruno
    Souala, Faouzi
    Arvieux, Cedric
    Rochcongar, Pierre
    Michelet, Christian
    HIV CLINICAL TRIALS, 2011, 12 (01): : 54 - 60
  • [50] A meta-analysis on the prevalence and characteristics of severe malaria in patients with Plasmodium spp. and HIV co-infection
    Mahittikorn, Aongart
    Kotepui, Kwuntida Uthaisar
    De Jesus Milanez, Giovanni
    Masangkay, Frederick Ramirez
    Kotepui, Manas
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345